1Thaker HK, Snow MH. HIV viral suppression in the era of antiretroviral therapy[J].Postgrad Med J,2003,79:36-42.
2Pancharoen C, Thisyakorn U. Stuart gan memorial lecture 2002,HIV/AIDS in children[J].Ann Acad Med Singapore,2003,32:235-238.
3Sharland M, Gibb DM, Tudor-Williams G. Advances in the prevention and treatment of pediatric HIV infection in the United Kingdom[J].Sex Transm Infect,2003, 79:53-55.
4Garcia PM,Kalish LA,Pitt J,et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group[J].N Engl J Med, 1999, 341:394-402.
5Kuhn L, Steketee RW, Weedon JA, et al. Distinct risk factors for intrauterine and intra-partum human immunodeficiency virus transmission and consequences for disease progression in infected children.perinatal AIDS collaborative transmission study[J]. J Infect Dis, 1999, 179:52-58.
6Ogundele MO, Coulter JB. HIV transmission through breastfee- ding: problems and prevention[J].Ann Trop Pediatr, 2003, 23:91-106.
7Becquart P, Hocini H, Levy M, et al. Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV[J]. J Infect Dis, 2000, 181:532-539.
8Abrams EJ, Wiener J, Carter R, et al. Maternal health factors and early pediatric antiretroviral therapy influence the rate of perinatal HIV-1 disease progression in children[J].AIDS, 2003, 17: 867-877.
9Mofenson LM, Lambert JS,Stiehm ER, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS clinical trials group study 185 team[J].N Engl J Med,1999, 341:385-393.
10Joseph P,McGowan, Sanjiv S,et al. Prevention of perinatal HIV transmission during pregnancy[J].J Antimicrobial Chemotherapy,2000,46:657-668.
